In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …

Introduction New direct oral anticoagulants (NOACs) constitute a novel treatment option for
acute venous thromboembolism (VTE), with practical advantages. Individual studies have …

Background Pulmonary embolism is one of the leading causes of maternal death in the
Western world. Because of the low specificity and sensitivity of the d-dimer test, all pregnant …

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary
embolism (PE) is relevant for management decisions but is currently unknown. We …

Introduction In the first wave, thrombotic complications were common in COVID-19 patients.
It is unknown whether state-of-the-art treatment has resulted in less thrombotic complications …

Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …

Pulmonary infarction results from occlusion of the distal pulmonary arteries leading to
ischemia, hemorrhage and ultimately necrosis of the lung parenchyma. It is most commonly …

Deep venous thrombosis (DVT) affecting the extremities is a common clinical problem.
Prompt imaging aids in rapid diagnosis and adequate treatment. While ultrasound (US) …

Essentials We performed a pooled analysis of 926 patients with cancer‐associated
incidental pulmonary embolism (IPE). Vitamin K antagonists (VKA) are associated with a …

Background Renal cell carcinoma (RCC) can be complicated by a venous tumor thrombus
(TT), of which the optimal management is unknown. Objectives This study sought to assess …